Digital RESI Pitch Session

Interested in Connecting? Please contact:
Jeff Livingstone
CEO
jlivingstone@igia-pharma.com

Message the company or request a 1:1 meeting here

Igia Pharmaceuticals, Inc (IGIA), is a privately held rare disease pharmaceutical development company incorporated in Delaware with main offices in Florence, Kentucky (just south of Cincinnati.) IGIA was created in March 2017 to develop products for the treatment of orphan and small population indications with unmet medical needs.

Pitch Video